Wheeler RH - Search Results

1

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

Robert F, Ezekiel MP, Spencer SA, Meredith RF, Bonner JA, Khazaeli MB, Saleh MN, Carey D, LoBuglio AF, Wheeler RH, Cooper MR, Waksal HW. Robert F, et al. Among authors: wheeler rh. J Clin Oncol. 2001 Jul 1;19(13):3234-43. doi: 10.1200/JCO.2001.19.13.3234. J Clin Oncol. 2001. PMID: 11432891 Clinical Trial.

2

Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: long-term follow-up of a phase I trial.

Robert F, Spencer SA, Childs HA 3rd, Zhang R, Meredith RF, Wheeler RH, Hawkins MH, Carey D. Robert F, et al. Among authors: wheeler rh. Lung Cancer. 2002 Aug;37(2):189-99. doi: 10.1016/s0169-5002(02)00029-6. Lung Cancer. 2002. PMID: 12140142 Clinical Trial.

3

Phase 2 study of prolonged administration of oral etoposide in combination with weekly cisplatin in advanced non-small cell lung cancer.

Robert F, Wheeler RH, Molthrop D, Bailey A, Chen S. Robert F, et al. Among authors: wheeler rh. Am J Clin Oncol. 1994 Oct;17(5):383-6. doi: 10.1097/00000421-199410000-00004. Am J Clin Oncol. 1994. PMID: 8092106 Clinical Trial.

4

Cisplatin plus radiation therapy.

Wheeler RH, Spencer S. Wheeler RH, et al. J Infus Chemother. 1995 Spring;5(2):61-6. J Infus Chemother. 1995. PMID: 8521236 Review.

5

Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer.

Meredith RF, Khazaeli MB, Plott WE, Spencer SA, Wheeler RH, Brady LW, Woo DV, LoBuglio AF. Meredith RF, et al. Among authors: wheeler rh. J Nucl Med. 1995 Dec;36(12):2229-33. J Nucl Med. 1995. PMID: 8523110 Free article. Clinical Trial.

6

Prolonged infusion of etoposide in patients with advanced non-small cell lung cancer.

Robert F, Molthrop DC, Miller AA, Lee BC, Chen S, Wheeler RH. Robert F, et al. Among authors: wheeler rh. Am J Clin Oncol. 1996 Oct;19(5):483-6. doi: 10.1097/00000421-199610000-00011. Am J Clin Oncol. 1996. PMID: 8823476

7

A phase II study of topotecan in patients with recurrent head and neck cancer. Identification of an active new agent.

Robert F, Soong SJ, Wheeler RH. Robert F, et al. Among authors: wheeler rh. Am J Clin Oncol. 1997 Jun;20(3):298-302. doi: 10.1097/00000421-199706000-00019. Am J Clin Oncol. 1997. PMID: 9167758 Clinical Trial.

8

Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer.

Meredith RF, Khazaeli MB, Plott WE, Grizzle WE, Liu T, Schlom J, Russell CD, Wheeler RH, LoBuglio AF. Meredith RF, et al. Among authors: wheeler rh. Clin Cancer Res. 1996 Nov;2(11):1811-8. Clin Cancer Res. 1996. PMID: 9816134 Clinical Trial.

9

Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck.

Spencer SA, Wheeler RH, Peters GE, Beenken SW, Meredith RF, Smith J, Conner W, Salter MM. Spencer SA, et al. Among authors: wheeler rh. Am J Clin Oncol. 1999 Feb;22(1):1-5. doi: 10.1097/00000421-199902000-00001. Am J Clin Oncol. 1999. PMID: 10025369

10

Monoclonal antibodies as potentiators of radiotherapy and chemotherapy in the management of head and neck cancer.

Wheeler RH, Spencer S, Buchsbaum D, Robert F. Wheeler RH, et al. Curr Opin Oncol. 1999 May;11(3):187-90. doi: 10.1097/00001622-199905000-00009. Curr Opin Oncol. 1999. PMID: 10328593 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters